Rockwell MedicalRMTI
About: Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
Employees: 244
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
506% more call options, than puts
Call options by funds: $109K | Put options by funds: $18K
3.21% less ownership
Funds ownership: 20.45% [Q1] → 17.24% (-3.21%) [Q2]
9% less funds holding
Funds holding: 46 [Q1] → 42 (-4) [Q2]
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
37% less capital invested
Capital invested by funds: $7.87M [Q1] → $5M (-$2.88M) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for RMTI.
Financial journalist opinion
Based on 5 articles about RMTI published over the past 30 days
